Co Diagnostics Stock Market Sentiment

CODX
 Stock
  

USD 2.98  0.12  3.87%   

Co Diagnostics investor sentiment overview provides quick insight into current market opportunities from investing in Co-Diagnostics. The current market sentiment together Co Diagnostics' historical and current headlines can help investors to time the market. Many technical investors use Co-Diagnostics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Continue to Co Diagnostics Hype Analysis, Co Diagnostics Correlation and Co Diagnostics Performance.
  
Co Diagnostics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Co Diagnostics daily returns and investor perception about the current pice of Co-Diagnostics as well as its diversification or hedging effects on your existing portfolios.

Co Diagnostics Historical Sentiment

Although Co Diagnostics' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Co Diagnostics, such as negative comments on social media and news outlets, may cause fear in the market and push Co Diagnostics' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Co Diagnostics.
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Co Diagnostics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Co-Diagnostics.

Co Diagnostics Sentiment by Major News Outlets

Co-Diagnostics Historical Investor Sentiment

Investor biases related to Co Diagnostics' public news can be used to forecast risks associated with investment in Co Diagnostics. The trend in average sentiment can be used to explain how an investor holding Co Diagnostics can time the market purely based on public headlines and social activities around Co-Diagnostics. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Co Diagnostics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Co Diagnostics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Co Diagnostics' news discussions. The higher the estimate score, the more favorable is the investor's outlook on Co Diagnostics.

Co-Diagnostics Twitter Pulse

Investors have realized that leveraging social media to get the fastest information affecting stock prices isn't a theory anymore, it is a reality, and Twitter offers a platform that can outpace even the most trustworthy news aggregators. The influence of social media outlets on stock markets and stock prices of entities such as Co-Diagnostics has been proven in recent years. We extract public sentiment from Twitter posts that could be utilized to determine whether Co Diagnostics' prices will increase or decrease.
Twitter's metrics such as likes, followers, and engagement can be good indicators of the reliance and probability of reaction to a specific tweet regarding Co-Diagnostics. Our Twitter sentiment analysis of Co Diagnostics Stock helps investors make informed decisions by leveraging the power of the community. It is a perfect supplementary tool for any beginner or an experienced trader.
2 days ago at news.google.com         
Why We Like The Returns At Integrated Diagnostics Holdings - Yahoo Finance
news
six days ago at news.google.com         
Lantheus Announces the Approval of DEFINITY by Chinas NMPA - Marketscreener.com
news
over a week ago at www.macroaxis.com         
Acquisition by Eugene Durenard of 11667 shares of Co Diagnostics subject to Rule 16b-3
Macroaxis News
over three weeks ago at news.google.com         
Investigation announced for Long-Term Investors in shares of Co-Diagnostics, Inc. over potentia - op...
news
over three weeks ago at news.google.com         
Motorcar Parts of America Reports Second Quarter Results - Marketscreener.com
news
over three weeks ago at news.google.com         
Myriad Genetics Releases FY 2022 Earnings Guidance - MarketBeat
news
over a month ago at news.google.com         
Co-Diagnostics delivers shareholders impressive 55 percent CAGR over 3 years, surging 12 percent in ...
news
over a month ago at news.google.com         
Investigation Alert UBER, CODX - GuruFocus.com
news
over a month ago at www.benzinga.com         
SHAREHOLDER ALERT The Gross Law Firm Notifies Shareholders of Co-Diagnostics, Inc. of a Class Action...
benzinga news
over a month ago at news.google.com         
Hologic Stock Got a Huge Boost From Covid. Inside Its Plan to Keep Growing. - Barrons
news
over a month ago at www.businesswire.com         
DiaCarta to Become a Publicly Listed Company Through Merger with HHL Acquisition Co. - Business Wire
businesswire News
over a month ago at www.prnewswire.com         
SHAREHOLDER ALERT The Gross Law Firm Notifies Shareholders of Co-Diagnostics, Inc. of a Class Action...
prnewswire News
over two months ago at news.google.com         
SHAREHOLDER ALERT Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Co-Diag...
news
over two months ago at www.benzinga.com         
CODX LOSS ALERT ROSEN, NATIONAL TRIAL COUNSEL, Encourages Co-Diagnostics, Inc. Investors to Secure C...
benzinga news
over two months ago at www.macroaxis.com         
Payment of 1414 shares by Reed Benson of Co Diagnostics subject to Rule 16b-3
Macroaxis News
Far too much social signal, news, headlines, and media speculation about Co Diagnostics that are available to investors today. That information is available publicly through Co Diagnostics media outlets and privately through word of mouth or via Co Diagnostics internal channels. However, regardless of the origin, that massive amount of Co Diagnostics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Co Diagnostics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Co Diagnostics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Co Diagnostics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Co Diagnostics alpha.

Co Diagnostics Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Co-Diagnostics CODX ALERT Hagens Berman, National Trial Atto...09/09/2022
2
Co-Diagnostics ROSEN, A TOP RANKED FIRM, Encourages Co-Diagn...09/15/2022
3
SHAREHOLDER ALERT The Gross Law Firm Notifies Shareholders o...09/21/2022
4
7 Vaccine Stocks to Sell ASAP Now That the Pandemics Over - ...09/27/2022
5
Payment of 1414 shares by Reed Benson of Co Diagnostics subj...09/29/2022
6
EPS Estimate09/30/2022
7
SHAREHOLDER ALERT Pomerantz Law Firm Reminds Shareholders wi...10/03/2022
8
Hologic Stock Got a Huge Boost From Covid. Inside Its Plan t...10/17/2022
9
Co-Diagnostics delivers shareholders impressive 55 percent C...11/02/2022
10
EPS Reported11/10/2022
11
Acquisition by Eugene Durenard of 11667 shares of Co Diagnos...11/23/2022
Continue to Co Diagnostics Hype Analysis, Co Diagnostics Correlation and Co Diagnostics Performance. Note that the Co-Diagnostics information on this page should be used as a complementary analysis to other Co Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for Co Diagnostics Stock analysis

When running Co-Diagnostics price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Is Co Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Co Diagnostics. If investors know Co Diagnostics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Co Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.31
Market Capitalization
92.1 M
Quarterly Revenue Growth YOY
(0.83) 
Return On Assets
0.0467
Return On Equity
0.13
The market value of Co-Diagnostics is measured differently than its book value, which is the value of Co Diagnostics that is recorded on the company's balance sheet. Investors also form their own opinion of Co Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Co Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Co Diagnostics' market value can be influenced by many factors that don't directly affect Co Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Co Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Co Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Co Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.